EBS
Emergent Biosolutions Inc
6.80$
+1.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 936.0% | 31.3% | – | 36.1% | 24.2% | 15.8% | 22.0% | 19.1% | 19.7% | 16.5% | 15.4% | 60.1% | 58.2% | 51.1% | 44.3% | 49.9% | 49.4% | 59.0% | 56.3% | 45.3% | 55.3% | 57.7% | 65.7% | 64.0% | 52.8% | |
| -836.0% | 68.7% | 100.0% | 63.9% | 75.8% | 84.2% | 78.0% | 80.9% | 80.3% | 83.5% | 84.6% | 39.9% | 41.8% | 48.9% | 55.7% | 50.1% | 50.6% | 41.0% | 43.7% | 54.7% | 44.7% | 42.3% | 34.3% | 36.0% | 47.2% | |
| 426.0% | 3.6% | – | 12.1% | 14.1% | 29.8% | 29.5% | 33.3% | 31.8% | 31.2% | 45.7% | 46.1% | 38.3% | 25.9% | 24.4% | 21.9% | 17.4% | 18.3% | 20.5% | 15.1% | 13.3% | 16.9% | 10.6% | 6.8% | 7.2% | |
| – | – | – | 48.4% | 46.8% | 59.0% | 30.4% | 30.8% | 31.4% | 26.6% | 27.2% | 27.0% | 28.1% | 30.4% | 30.3% | 29.4% | 25.6% | 25.9% | 24.7% | 19.2% | 19.6% | 30.5% | 35.5% | 29.5% | 25.1% | |
| 1,919.0% | 20.6% | – | 48.4% | 39.2% | 59.0% | 59.9% | 64.2% | 63.2% | 57.8% | 72.8% | 28.6% | 28.1% | 26.8% | 26.8% | 28.5% | 28.4% | 29.5% | 33.4% | 26.9% | 25.5% | 57.5% | 103.5% | 46.4% | 32.4% | |
| -0.8% | 48.1% | 100.0% | 20.1% | 16.3% | 24.9% | 18.1% | 16.8% | 17.1% | 25.7% | 11.7% | 13.0% | 13.7% | 22.1% | 28.9% | 21.6% | 22.2% | 11.5% | 10.3% | 27.8% | 19.2% | -15.2% | -69.2% | -10.4% | 14.8% | |
| 82.3% | 0.0% | 0.0% | 0.0% | 0.0% | 0.5% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 2.0% | 1.3% | 1.6% | 1.2% | 1.3% | 3.5% | 2.0% | 1.9% | 3.3% | 8.4% | 6.8% | 8.0% | |
| -1.2% | 47.3% | – | 19.9% | 16.2% | 24.9% | 19.7% | 18.3% | 17.7% | 25.6% | 11.7% | 11.4% | 13.9% | 20.8% | 27.7% | 20.3% | 21.1% | 10.4% | 7.0% | 26.1% | 17.1% | -19.6% | -69.7% | -13.7% | 11.1% | |
| 4.6% | 0.9% | -8.0% | 6.1% | 4.1% | 10.0% | 7.1% | 6.8% | 6.4% | 9.1% | 5.8% | 4.9% | 4.2% | 7.4% | 9.1% | 7.5% | 6.4% | 2.4% | 2.1% | 6.7% | 4.7% | -0.7% | 2.8% | 4.6% | 4.1% | |
| -1.2% | 46.3% | 8.0% | 13.7% | 12.1% | 14.9% | 12.5% | 11.6% | 13.3% | 18.1% | 8.4% | 8.3% | 10.0% | 9.1% | 12.8% | 10.6% | 14.7% | 8.0% | 4.9% | 19.4% | 12.4% | -18.9% | -72.5% | -18.3% | 7.1% | |
| 100.0% | 48.1% | 100.0% | 22.4% | 19.5% | 28.7% | 20.7% | 20.7% | 19.8% | 27.7% | 15.1% | 16.9% | 20.8% | 30.1% | 38.1% | 27.2% | 31.1% | 19.8% | 23.4% | 38.6% | 28.4% | 1.4% | -4.5% | 5.1% | 32.4% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.